System Harnesses Fully Automated TurboMatrix™ Headspace Sampler and Meets ASTM D3612 Part A and C Standards
ORLANDO, Fla. – PerkinElmer, Inc. (NYSE: PKI ), a leading provider of drug discovery, life science research and analytical solutions, today announced its new PerkinElmer-Arnel ™ TOGA gas chromatography system for the analysis of transformer oil fault gases using headspace sampling at PITTCON® 2005, Booth 4728. Having served the power industry for years, the PerkinElmer-Arnel TOGA (Transformer Oil and Gas Analyzer) has now been integrated with PerkinElmer's TurboMatrix™ Headspace Sampler, permitting complete automation for transformer fault gas analysis.
The American Society for Testing and Materials ( ASTM ) Method D3612 Part A and B have been the standard methods for fault gas analysis in the electrical industry to date. This traditional method is extremely labor-intensive and time-consuming and specifies that the analysis of hydrogen, oxygen, nitrogen, carbon monoxide, carbon dioxide, methane, ethane, ethylene and acetylene are required for identification and quantification. A new Part C has been recently introduced and now lab technicians, scientists and quality assurance chemists in the power industry using large, oil insulated transformers have a new fully automated option for the analysis of fault gas in the PerkinElmer-Arnel TOGA gas chromatograph.
“By combining our TurboMatrix Headspace Sampler technology with our TOGA analyzer we can now offer technicians a fully automated and compliant solution for transformer fault gas analysis,” said Jonathan Rennert, vice president and general manager of the Environmental & Chemical business at PerkinElmer. “We believe this product will have a direct impact on the level of accuracy in transformer fault gas analysis worldwide.”
“The new TOGA analyzer is yet another wonderful product as a result of our collaboration with PerkinElmer. Our goal in the design of the new analyzer was to allow for more efficient analysis of transformer fault gas, while meeting all necessary industry standards,” said Clarence Wentzel, president of Arnel, Inc. “ The collaboration between Arnel and PerkinElmer continues to expand application-specific options for a growing number of customers.”
The new TOGA analyzer is a product of a PerkinElmer and Arnel Inc . agreement to jointly engineer and market special products. With the addition of PerkinElmer's TurboMatrix Headspace Sampler to the TOGA system, technicians can now expand on the traditional method of analysis and allow for headspace sampling of insulating oils. The new fully automated TOGA analyzer is completely compliant with ASTM Method D3612 Part A and C standards.
Available in three different models (16, 40 or 110 sample capacity), the TurboMatrix Headspace Samplers eliminate tedious and error-producing steps required in Part A. Complete automation of sample preparation and analysis is accomplished through the use of the headspace sampler, significantly increasing throughput and precision.
Continuing its 50-year tradition of GC innovation, PerkinElmer is the only supplier that manufactures and sells a complete single-vendor solution – from sample handling to data handling.
For more information about the system, contact PerkinElmer at 1-800-762-4000 or Arnel at 1-732-721-4300 or visit the PerkinElmer Web site at www.perkinelmer.com.
Factors Affecting Future Performance
This press release contains 'forward-looking' statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements contained in this press release that relate to prospective events or developments are deemed to be forward-looking statements. Words such as 'believes,' 'anticipates,' 'plans,' 'expects,' “projects,” “forecasts,” 'will' and similar expressions are intended to identify forward-looking statements. There are a number of important risk factors that could cause actual results or events to differ materially from those indicated by these forward-looking statements, including risks related to cyclical downturns affecting several of the industries into which we sell our products, our failure to introduce new products in a timely manner, the impact of our debt on our cash flow and investment opportunities, our ability to comply with financial covenants contained in our credit agreements and debt instruments, risks related to our international operations, our ability to adjust our operations to address unexpected changes, our ability to execute acquisitions and license technologies and successfully integrate acquired businesses and licensed technologies into our existing business, the loss of any of our licenses that may require us to stop selling products or lose competitive advantage, competition, regulatory changes, our failure to obtain and enforce intellectual property protection, our defense of third party claims of patent infringement and our ability to realize the full value of our intangible assets, as well as other factors which we describe under the caption 'Forward-Looking Information and Factors Affecting Future Performance' in our most recently filed annual report on Form 10-K and in our most recently filed quarterly report on Form 10-Q. We disclaim any intention or obligation to update any forward-looking statements as a result of developments occurring after the date of this press release.
PerkinElmer, Inc. is a global technology leader focused in the following businesses - Life and Analytical Sciences, Optoelectronics and Fluid Sciences. Combining operational excellence and technology expertise with an intimate understanding of our customers' needs, PerkinElmer provides products and services in health sciences and other advanced technology markets that require innovation, precision and reliability. The Company serves customers in more than 125 countries, and is a component of the S&P 500 Index. Additional information is available through www.perkinelmer.com or 1-877- PKI -NYSE.